Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Jaguar Animal Health, Inc. (JAGX) had Revenue of $11.69M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$11.69M
Net Income	$-38.49M
Cost of Goods Sold	$1.96M
Gross Profit	$9.73M
Operating Expenses	$42.52M
Operating Income	$-30.83M
Non-Operating Income/Expense	$-8.42M
Pre-Tax Income	$-39.25M
Normalized Pre-Tax Income	$-39.25M
Income after Taxes	$-39.25M
Income from Continuous Operations	$-39.25M
Consolidated Net Income/Loss	$-39.25M
Normalized Income after Taxes	$-39.25M
EBIT	$-30.83M
EBITDA	$-28.20M
Weighted-Average Shares Outstanding (Basic)	0.29M
Weighted-Average Shares Outstanding (Diluted)	0.29M
Earnings per Share (EPS) (Basic)	$-130.69
Earnings per Share (EPS) (Diluted)	$-130.69
Balance Sheet Financials
Current Assets	$32.20M
Property, Plant, and Equipment	$0.46M
Long-Term Assets	$21.23M
Total Assets	$53.42M
Current Liabilities	$19.70M
Long-Term Debt	$23.50M
Long-Term Liabilities	$27.23M
Total Liabilities	$46.93M
Common Equity	$6.49M
Tangible Shareholders Equity	$-11.98M
Shareholders Equity	$6.49M
Common Shares Outstanding	0.53M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-29.38M
Cash Flow from Investing Activities	$-0.23M
Cash Flow from Financial Activities	$31.20M
Beginning Cash	$6.47M
End Cash	$8.00M
Increase/Decrease in Cash	$1.53M
Stock-Based Compensation	$1.65M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.63
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.78
Debt to Equity Ratio	5.47
Gross Margin	83.27%
Operating Margin	-263.76%
EBIT Margin	-263.76%
EBITDA Margin	-241.24%
Pre-Tax Profit Margin	-335.79%
Profit Margin	-329.30%
Free Cash Flow	$-29.40M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.22
Inventory Turnover	0.19
Receiveable Turnover	7.10
Days Sales in Receivables	51.43
Return on Equity	-604.42%
Return on Tangible Equity	327.50%
Return on Assets	-73.47%
Return on Investments	-130.85%
Book Value Per Share	$12.30
Free Cash Flow per Share	$-99.82
Operating Cash Flow per Share	$-99.76

Data from Zacks Investment Research, Inc.